Kite Pharma, Inc.
KITE
KITE was delisted on the 2nd of October, 2017.
155 hedge funds and large institutions have $1.86B invested in Kite Pharma, Inc. in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 62 increasing their positions, 49 reducing their positions, and 22 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 49
21% more call options, than puts
Call options by funds: $41M | Put options by funds: $34M
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
2% more capital invested
Capital invested by funds: $1.82B → $1.86B (+$38.7M)
0% more funds holding
Funds holding: 155 → 155 (0)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$113M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31M |
| 3 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$25.2M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$23.5M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$22.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$16.2M |
| 2 |
JP Morgan Chase
New York
|
-$10.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.37M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.35M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$8M |
KITE Hedge Fund Activity: Q3 2015 in Review
155 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q3 2015, worth a combined $1.86B — up 2.1% from $1.82B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new KITE positions and 22 closed out — a net gain of 1 holder — while 62 added to existing stakes and 49 trimmed.
The largest buyer was Viking Global Investors, adding an estimated $113M. The largest seller was Frontier Capital Management, cutting an estimated $16.2M.
- 155 institutional investors held Kite Pharma, Inc. (KITE) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $1.86B of Kite Pharma, Inc. stock for Q3 2015, up 2.1% quarter-over-quarter.
- 23 funds opened new Kite Pharma, Inc. positions in Q3 2015 and 22 closed out, a net change of +1 holder.
- The largest Kite Pharma, Inc. buyer in Q3 2015 was Viking Global Investors, an estimated $113M added.
- The largest Kite Pharma, Inc. seller in Q3 2015 was Frontier Capital Management, an estimated $16.2M sold.
Based on aggregated 13F filings for Q3 2015.